Term
Predisposing Factors for Oral Candidiasis |
|
Definition
Immunological Factors Old Age/Infancy Radiation/Chemo AIDS
Endocrine Abnormalities Diabetes Hypothyroidism Corticosteroid Therapy
|
|
|
Term
Topical Antifungal Treatment Rationale (Oral Candidiasis) |
|
Definition
Uncomplicated localized infection in patients with normal immune function. Medication should be continued for 48 hrs after clinical signs disappear. |
|
|
Term
Systemic Antifungal Treatment Rational (Oral Candidiasis) |
|
Definition
Disseminated or multi-focal disease Immunocompromised patients |
|
|
Term
|
Definition
Class: Polyene Dosage Form: Topical Site of Action: Cell Membrane [image] Drug of choice for fungal infections of the oral cavity. Broad spectrum of activity (Candida, Histoplasmosis, Cryptococcus). Used prophylactically in immunocompromised patients. Not absorbed from the skin or mucosal membranes (GI Tract). Too toxic for parenteral use; only used topically. Dosage Forms: Oral Suspension 100,000 u/mL -- Rinse mouth with 5 mL for at least 2 minutes qid (4x/day) pc (after meals) and hs (at bedtime), then swallow; NPO 30 minutes after use Lozenges 200,000 units -- dissolve completely in mouth (do not chew or swallow whole) 5 times per day; NPO 30 minutes after use Both treatments usually last 14 days Patients say it has a bitter, foul taste
|
|
|
Term
|
Definition
Class: Polyene Dosage Form: Topical, IV Site of Action: Cell Membrane [image] Dosage Forms: IV - Binds to cholesterol in plasma membranes; most toxic antibiotic in current use; given over a period of 2-6 hrs; Adverse Effects: hypotension, delirium, fever, nausea, vomiting, abdominal pain, anorexia, headache, nephrotoxicity; AKA "amphoterrible"
|
|
|
Term
|
Definition
Class: Imidazole Dosage Form: Topical Site of Action: Cell Membrane [image] Nitrogen atoms of the azole ring bind to lanosterol 14-α-demethylase. The conversion of lanosterol to ergosterol is inhibited. Ergosterol is part of the cell membrane. Only used topically because it is not absorbed from the GI tract. Drug of choice for oral candidiasis in patients with AIDS. Binds to the oral mucosa, gradually released, fugistatic concentrations for several hours. Dosage Forms: |
|
|
Term
|
Definition
Class: Imidazole Dosage Form: Topical, PO Site of Action: Cell Membrane [image] Nitrogen atoms of the azole ring bind to lanosterol 14-α-demethylase. The conversion of lanosterol to ergosterol is inhibited. Ergosterol is part of the cell membrane. Dosage Forms: Adverse Effects: hepatoxicity (0.01%). Inhibits synthesis of testosterone and estradiol. Inhibitor of Cytochrome p450 3A4 (metabolizes Cyclosporin, Phenytoin, Sulfonylureas, Warfarin). Seldom used. |
|
|
Term
|
Definition
Class: Triazole Dosage Form: IV, PO Site of Action: Cell Membrane [image] A triazole derivative: more selective inhibitor of fungal cell membrane p450. Adverse Effects: GI upset, less hepatoxicity than ketoconazole. Weak inhibitor of Cytochrome p450 3A4. Dosage Forms: Tablet 100 mg -- 2 tabs PO stat, then 1 tab PO qd for 13 days (14 days total) Oral Suspension 50 mg/5 mL --Rinse mouth with 20 mL on day 1 for 1 minute then swallow. Repeat with 10 mL qd for 13 days (14 days total)
Resistance to Fluconzaole: |
|
|
Term
|
Definition
Class: Triazole Dosage Form: IV, PO Site of Action: Cell Membrane [image] Triazole, mechanism like fluconazole. Significant inhibitor of p450 3A4. Used if infection is resistant to nystatin, ketoconazole, fluconazole. Resistance in Candida species isolated from patients on prolonged therapy. Dosage Forms: |
|
|
Term
|
Definition
Class: Hydroxyquinoline Dosage Form: Topical Halogenated hydroxyquinoline with amebicidal, antitrichomonal, antibacterial, and antifungal activity. Chelates trace metals at bacterial surfaces that are essential for growth. Indicators: angular cheilitis
Dosage Forms: |
|
|
Term
Other Antifungal Treatments |
|
Definition
Griseofulvin: ringworm infections of the scalp, skin, and nails (site of action = cell membrane) Flucytosine and amphotericin: systemic candidiasis and cryptococcosis (site of action = nucleic acid synthesis) |
|
|
Term
Treatment Regimen for Oral Candidiasis in Immunocompetent Patients |
|
Definition
Clotrimazole Lozenges 10 mg Nystatin Lozenges 200,000 units -- Dissolve slowly in mouth (do not chew or swallow whole) 5 times per day; NPO 30 minutes after use Fluconazole tablets 150 mg --Take 1 tablet PO stat
|
|
|
Term
Treatment Regimen for Oral Candidiasis in Immunocompromised Patients or Mucocutaneous Candidiasis |
|
Definition
Fluconazole Oral Suspension 50 mg/5 mL Itraconazole Oral Suspension 10 mg/mL -- Rinse mouth with 20 mL for 1 minute then swallow qd and continue for 14 days Fluconazole tablets 100 mg -- Take 2 tablets PO stat, then 1 tablet PO qd for 13 days (14 days total)
|
|
|
Term
Treatment Regimen for Chronic Atrophic Candidiasis Associated with a Denture |
|
Definition
Nystatin Cream 100,000 u/g Clotriamazole Cream 1% Ketoconazole Cream 2% Apply thin coat of medicine to entire inner surface of denture after each meal for 14 days.
More denture treatments: Full strength bleach (only for dentures without metal) -- soak for 10 minutes once a week then rinse well Anti-fungal Vaginal tablets -- dissolve tablet in water, soak denture for 10 minutes
|
|
|